Lumigenex is a fast growing biotechnology company dedicated to the development of proprietary technologies that meet the ever increasing demands on clinical diagnostics. Lumigenex is focused on developing cost-effective rapid diagnostic products based on our patented Time Resolved Fluorescence Immunoassay (TRFIA) platform with primary areas of interests in cardiology, women's health, infectious disease, oncology and drugs of abuse. Closely collaborating with our global strategic partners, Lumigenex is committed to becoming a worldwide leader in the fields of quantitative POCT.
CEO & Co-Founder, Zapnito
Sales Account Executive, Springer Nature
Former Head of Communities, Springer Nature
Chief Product Officer, Zapnito